Precision Vaccinations News
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Dengue
Flu
Measles
RSV
STD
Travel
Vaccines
Pneumococcal
Fact checked by
Robert Carlson, MD
May 24
5 min read
Pfizer Completes Third Phase Three 20vPnC Vaccine Study
PF-06482077 is a 20-Valent pneumococcal conjugate vaccine candidate (20vPnC) helping protect people from invasive pneumococcal disease and pneumonia
Pneumococcal
Fact checked by
Robert Carlson, MD
Apr 27
3 min read
$120 Million Financing to Advance MAPS Vaccines
Affinivax ASP3772 vaccine is currently being studied in pneumococcal infection in seniors
Pneumococcal
Fact checked by
Robert Carlson, MD
Mar 18
4 min read
Pneumococcal Conjugate Vaccine Candidate Expected to Meet Licensure Criteria
Adult 20vPnC vaccine candidate indicated for the majority of currently circulating pneumococcal disease
Pneumococcal
Fact checked by
Robert Carlson, MD
Feb 22
3 min read
$3 Million Vaccine Development Awarded To Combat Pneumococcus
VaxNewMo bioconjugation technology for vaccine development gains funding
Pneumococcal
Pneumonia
Sepsis
Fact checked by
Robert Carlson, MD
Jan 19
5 min read
Clearing Up Pneumococcal Vaccine Questions
PPSV23 pneumococcal vaccination recommendations have undergone several changes
Pneumococcal
Pneumonia
Show more